US · IRTC
iRhythm Technologies, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- San Francisco, CA 94103
- Website
- irhythmtech.com
Price · as of 2025-12-31
$120.80
Market cap 4.32B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $114.97 | -4.83% |
| Intrinsic Value(DCF) | $288.94 | +139.19% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | $0.00 | $0.00 | |||
| 2015 | $0.00 | $0.00 | |||
| 2016 | $35.27 | $54.29 | $20,141.74 | $0.00 | $0.00 |
| 2017 | $66.94 | $56.57 | $3,362.02 | $0.00 | $0.00 |
| 2018 | $88.18 | $59.24 | $2,234.52 | $0.00 | $0.00 |
| 2019 | $95.72 | $67.01 | $1,121.80 | $0.00 | $0.00 |
| 2020 | $141.12 | $89.93 | $251.38 | $4.38 | $0.00 |
| 2021 | $118.62 | $64.81 | $69.55 | $0.00 | $0.00 |
| 2022 | $107.27 | $73.68 | $56.87 | $0.00 | $0.00 |
| 2023 | $111.66 | $58.94 | $41.36 | $0.00 | $0.00 |
| 2024 | $101.75 | $132.72 | $20.66 | $0.00 | $0.00 |
| 2025 | $128.46 | $114.97 | $205.87 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates iRhythm Technologies, Inc.'s (IRTC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $114.97
- Current price
- $120.80
- AI upside
- -4.83%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$288.94
+139.19% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| IRTC | iRhythm Technologies, Inc… | $120.80 | 4.32B | -5% | +139% | — | — | -92.28 | 26.92 | 5.50 | -1074.06 | — | 27.07 | 70.57% | -4.93% | -5.96% | -36.57% | -12.43% | -4.57% | 4.79 | -2.80 | 4.63 | 4.34 | -124.89 | -6171.00% | 2624.00% | -21299.00% | 0.84% | 0.53 | 11.65% | 0.00% | 0.00% | 0.00% | -115.69 | 123.36 | 5.70 | 3.00 |
| ARWR | Arrowhead Pharmaceuticals… | $63.27 | 8.86B | +5,558% | +96,147% | -95% | — | 272.90 | 17.63 | 9.91 | 46.50 | — | 17.90 | 97.12% | 11.86% | -0.20% | 9.24% | 42.67% | 2.39% | 0.79 | 1.10 | 4.86 | 4.74 | 0.85 | -9976.00% | 2325815.00% | -12596.00% | 1.91% | 0.92 | 116.49% | 0.00% | 0.00% | 7.42% | 77.94 | 48.86 | 9.24 | 5.43 |
| BLCO | Bausch + Lomb Corporation | $18.30 | 6.48B | +52% | -60% | — | — | -18.50 | 1.01 | 1.28 | 20.11 | -138.78 | -4.09 | 58.71% | 3.12% | -7.06% | -5.45% | 1.41% | -2.56% | 0.83 | 0.37 | 1.55 | 0.84 | 8.72 | 1333.00% | 647.00% | 1186.00% | -1.01% | 0.15 | -0.59% | 0.00% | 0.00% | 0.00% | 72.33 | -174.25 | 2.25 | 0.92 |
| BRKR | Bruker Corporation | $40.11 | 6.09B | -2% | -60% | -66% | — | 206.96 | 2.44 | 1.76 | 17.43 | — | -7.46 | 45.61% | 6.30% | -0.25% | 1.37% | 2.20% | 0.48% | 0.76 | 4.69 | 1.73 | 0.66 | 3.59 | -11974.00% | 208.00% | -6816.00% | 0.72% | 0.10 | 1.10% | 0.38% | 78.10% | 8.68% | 35.15 | 175.83 | 2.22 | 1.82 |
| BTSG | BrightSpring Health Servi… | $41.43 | 7.47B | +60% | +485% | -97% | -50% | 44.17 | 4.49 | 0.65 | 24.32 | — | -6.86 | 11.76% | 3.06% | 1.48% | 10.82% | 6.59% | 3.09% | 1.52 | 2.51 | 1.57 | 0.58 | 5.99 | -102949.00% | 1459.00% | -79075.00% | 4.69% | 0.27 | 8.65% | 0.00% | 0.00% | 1.57% | 28.26 | 28.32 | 0.87 | 3.51 |
| CHE | Chemed Corporation | $410.01 | 5.97B | -25% | -56% | -80% | -46% | 22.87 | 6.19 | 2.40 | 14.53 | — | 26.42 | 29.97% | 13.37% | 10.48% | 25.28% | 23.68% | 16.54% | 0.15 | 193.28 | 1.05 | 0.90 | 0.16 | -739.00% | 406.00% | -1155.00% | 5.36% | 1.35 | 30.56% | 0.52% | 11.90% | 7.63% | 18.14 | 18.85 | 2.43 | 9.79 |
| CRSP | CRISPR Therapeutics AG | $60.14 | 5.77B | -40% | -46% | — | +738% | -9.40 | 2.84 | 1556.91 | -7.08 | -19.15 | 2.84 | -6537.01% | -16191.40% | -16569.77% | -30.18% | -191.73% | -25.81% | 0.21 | — | 13.32 | 13.25 | -0.07 | 4908.00% | -8997.00% | 13911.00% | -6.33% | -2.31 | -116.70% | 0.00% | 0.00% | 0.00% | -6.83 | -11.23 | 1106.51 | 8.49 |
| GKOS | Glaukos Corporation | $120.40 | 6.99B | -42% | +3% | — | — | -51.83 | 10.56 | 13.65 | -45.16 | -281.48 | 15.48 | 55.72% | -39.33% | -36.99% | -18.78% | -36.24% | -14.31% | 0.21 | -43.06 | 4.69 | 3.82 | -0.32 | 1841.00% | 3233.00% | -2013.00% | -0.78% | -0.46 | -10.09% | 0.00% | 0.00% | 0.00% | -34.01 | -125.68 | 13.38 | 16.38 |
| PCVX | Vaxcyte, Inc. | $61.74 | 8.86B | — | — | — | — | -11.00 | 3.14 | — | -9.58 | -22.85 | 3.14 | 0.00% | — | — | -25.59% | -61.93% | -23.38% | 0.09 | — | 7.91 | 7.81 | -0.07 | 4816.00% | — | 4089.00% | -7.93% | -3.19 | -44.87% | 0.00% | 0.00% | 0.00% | -7.69 | -10.61 | — | 12.61 |
| RDNT | RadNet, Inc. | $69.81 | 5.4B | -49% | -62% | -96% | -99% | 94.62 | 4.07 | 2.01 | 17.76 | — | 33.32 | 13.62% | 5.72% | 0.15% | 5.07% | 4.94% | 1.30% | 1.92 | 1.31 | 2.12 | 2.02 | 3.77 | -2059.00% | 1318.00% | 156.00% | 1.22% | 0.49 | 2.45% | 0.00% | 0.00% | 4.35% | 44.57 | 103.74 | 2.55 | 1.85 |
| TFX | Teleflex Incorporated | $122.06 | 5.39B | -20% | -55% | — | +315% | -6.06 | 1.76 | 2.75 | 17.49 | — | -7.79 | 56.24% | 2.94% | -45.45% | -24.47% | 1.35% | -12.90% | 0.06 | 0.58 | 2.54 | 0.95 | -0.64 | -146824.00% | -3461.00% | -9972.00% | 0.03% | 0.13 | 0.03% | 1.10% | -6.70% | 36.82% | 90.40 | 3659.08 | 2.66 | 2.01 |
About iRhythm Technologies, Inc.
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
- CEO
- Quentin S. Blackford
- Employees
- 2K
- Beta
- 1.07
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($288.94 ÷ $120.80) − 1 = +139.19% (DCF, example).